Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells

被引:11
|
作者
Sharma, Shaveta [1 ]
Kaul, Deepak [1 ]
Arora, Mansi [1 ]
Malik, Deepti [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Mol Biol Unit, Dept Expt Med & Biotechnol, Chandigarh 160012, India
关键词
Cancer cells; DNMT3B; Mutant-AATF; Oncogenomics; AUTOPHAGY; APOPTOSIS; P53; SURVIVAL; CHE-1;
D O I
10.1002/cbin.10379
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since apoptosis presents a natural defense in cancer development, the anti-apoptotic factor AATF/Che-1 has emerged as a crucial Epigenomic-Switch'. We have tried to understand the double-edged nature of AATF, showing for the first time the conspicuous existence of an aberrant AATF/Che-1 transcriptome encoding for 23kDa mutant AATF protein, which evolves its unique interactome within human cancer cells derived from different tissue origins. This mutant AATF along with its interactome consisting of SP1, DNMT3B and Par-4 ensures cancer cell DNA methylation required for down-regulation of tumor suppressor genes. Hence, the proposed mutant AATF interactome-based pathway can have the inherent ability to ensure human cells become and remain cancerous.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [41] Integrated Phosphoproteomics for Identifying Substrates of Human Protein Kinase A (PRKACA) and Its Oncogenic Mutant DNAJB1-PRKACA
    Karamafrooz, Adak
    Brennan, Jack
    Thomas, David D.
    Parker, Laurie L.
    JOURNAL OF PROTEOME RESEARCH, 2021, 20 (10) : 4815 - 4830
  • [42] Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells
    Giorgio Giurato
    Giovanni Nassa
    Annamaria Salvati
    Elena Alexandrova
    Francesca Rizzo
    Tuula A. Nyman
    Alessandro Weisz
    Roberta Tarallo
    Scientific Data, 5
  • [43] A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis
    Joyce, T.
    Oikonomou, E.
    Kosmidou, V.
    Makrodouli, E.
    Bantounas, I.
    Avlonitis, S.
    Zografos, G.
    Pintzas, A.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (07) : 873 - 898
  • [44] Oncogenic β-catenin is required for bone morphogenetic protein 4 expression in human cancer cells
    Kim, JS
    Crooks, H
    Dracheva, T
    Nishanian, TG
    Singh, B
    Jen, J
    Waldman, T
    CANCER RESEARCH, 2002, 62 (10) : 2744 - 2748
  • [45] Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells
    Giurato, Giorgio
    Nassa, Giovanni
    Salvati, Annamaria
    Alexandrova, Elena
    Rizzo, Francesca
    Nyman, Tuula A.
    Weisz, Alessandro
    Tarallo, Roberta
    SCIENTIFIC DATA, 2018, 5
  • [46] Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells
    Arunkumar, Ganesan
    Baek, Songjoon
    Sturgill, David
    Bui, Minh
    Dalal, Yamini
    SCIENCE ADVANCES, 2022, 8 (09)
  • [47] Oncogenic lncRNAs alter epigenetic memory at a fragile chromosomal site in human cancer cells
    Arunkumar, G.
    Baek, S.
    Sturgill, D.
    Bui, M.
    Dalal, Y.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 1013 - 1014
  • [48] MUC1 alters oncogenic events and transcription in human breast cancer cells
    Hattrup, Christine L.
    Gendler, Sandra J.
    BREAST CANCER RESEARCH, 2006, 8 (04)
  • [49] MUC1 alters oncogenic events and transcription in human breast cancer cells
    Christine L Hattrup
    Sandra J Gendler
    Breast Cancer Research, 8
  • [50] Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS
    Chen, Yi-Ting
    Huang, Zi-Yi
    Tang, Han-Hsuan
    Kuo, Wan-Ting
    Wu, Shan-Ying
    Lan, Sheng-Hui
    Chang, Kai-Hsun
    Lin, Pin-Lun
    Lee, Ming-Fen
    Cheng, Hung-Chi
    Liu, Hsiao-Sheng
    Huang, Chi-Ying F.
    Huang, Guan-Cheng
    Su, Chun-Li
    CANCERS, 2020, 12 (10) : 1 - 25